Trials / Completed
CompletedNCT01464047
Korean Post-marketing Surveillance for Sprycel®
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 670 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this post-marketing surveillance is to investigate and confirm the type and incidence of newly identified adverse events and any other factors affecting safety and efficacy of Sprycel® so that the regulatory authority can manage the marketing approval properly.
Conditions
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2015-08-01
- Completion
- 2015-08-01
- First posted
- 2011-11-03
- Last updated
- 2016-04-27
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01464047. Inclusion in this directory is not an endorsement.